GRP78 antibodies are associated with blood-brain barrier breakdown in paraneoplastic cerebellar degeneration in Lambert-Eaton myasthenic syndrome.
GRP78 antibodies are associated with blood-brain barrier breakdown in paraneoplastic cerebellar degeneration in Lambert-Eaton myasthenic syndrome.
复制标题
GRP78 抗体与兰伯特-伊顿肌无力综合征副肿瘤性小脑变性的血脑屏障破坏相关。
DOI:
10.1111/cen3.12575
复制
发表时间:
2020
期刊:
影响因子:
--
通讯作者:
Kanda T.
中科院分区:
文献类型:
--
作者:
Shimizu F;Kanda T.
GRP78 antibodies are associated with blood-brain barrier breakdown in paraneoplastic cerebellar degeneration in Lambert-Eaton myasthenic syndrome Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune neuromuscular junction disease associated with P/Q-type voltage-gated calcium channels (P/Q-type VGCCs) autoantibodies.[1] P/Q-type VGCCs present at the presynaptic motor nerve terminals and their antibodies induce a reduction in neurotransmitter release, leading to the characteristic muscle weakness associated with the disease. BBB, blood-brain barrier; CNS, central nervous system; LEMS, Lambert-Eaton myasthenic syndrome; PCD, paraneoplastic cerebellar degeneration; VGCC, voltage-gated calcium channel gl CONFLICT OF INTEREST None declared.[Extracted from the article]Copyright of Clinical & Experimental Neuroimmunology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. Copyright applies to all Abstracts.